All Type of News
KPA to form civil service task force team.
The Korea pharmaceutical association (KPA) held the 2nd meeting for the city and provincial KPA executives at Imperial Palace hotel on March 26 and determined to form a task force team for the resolution of many probl...
Jeil to split stocks into 500 won par value.
In the 46th general shareholder's meeting on March 17 Jeil decided to amend partly the Article of Incorporation reflecting the current stock of 5000 won par value to split in 500 won.
The company reported the 2005 ...
NHI reimbursement for 191 new products.
Taking effect from April 1, the total 191 drugs including Il Dong's Tomamed 100mg and Hanmi's Topira tab. (all anti-epileptic drug) are newly reimbursable from the NHI scheme, of which the price of 5 drugs rose but 2 ...
LG and Hanmi at the top NHI drug bills of Korean drug makers.
According to "Top 100 drugs billed for NHI reimbursement in 2004 and 2005" disclosed by Rep. Ahn Myeong-ok, all foreign branded drugs occupied the top 10 except 2 domestic drugs such as LG's Zanidip and Hanmi's Amodi...
Zuellig to supply Bausch Rom products at 10% price increase.
Zuellig Pharma will supply Bausch Rom products. According to a reliable source on March 17, "Y" company who supplied exclusively Bausch Rom products through wholesalers only has made an exclusive distribution agreemen...
First Botox generic to be marketed by Meditox.
Meditox, a Korean bio venture company, has obtained the KFDA approval for the sale of "botulism injection", a generic of Botox, through their own technical development.
The development of an injectable botulism by ...
Handok to launch Tritace Protect.Handok launched a cardiovascular protective drug called "Tritace Protect" (ramipril 10mg) in to the Korean market, which was earlier proven of its therapeutic benefits through t...
|
Detailed standards for drug small packages until March 31.
The detailed standards for the drug small package supply seems to be settled down before the end of March after extracting an agreement between KPA and KPMA.
The KFDA took the 2nd Drug Small Package Task Force Meet...
Major drug maker's shareholder's meeting report in 2005.
Dong-A decided to pay 2% in stake and 12% in cash for shareholders.
In the shareholder meeting at the office auditorium on March 17 Dong-A management announced the dividends at 2% in stock and 12% in cash and appoi...
KFDA to review data exemption for combined drug registration.
The KFDA said in the brief talk meeting with the pharmaceutical companies of developing a combined anti-diabetic drug that the standards required for the combined drug registration data should be wholly reviewed to an...
